U.S. Endoscopy Video Processor Market, by Product Type (Video Processors with Display and Video Processors without Display), by Application (Upper GI Endoscopy, Colonoscopy, Bronchoscopy, Sigmoidoscopy, ENT Endoscopy, and Others), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), was valued at US$ 196.5 Million in 2021 and is projected to exhibit a CAGR of 4.3% during the forecast period (2021-2028).
Rapid innovation in endoscopy technologies is expected to drive growth of the endoscopy video processor market. New development in the field of endoscopy video processors offer versatile and efficient imaging platform. Furthermore, these endoscopy video processors offers compatibility to a wide range of endoscopes and multiple different observation methods such as 3D visualization and special light observation. For instance, in April 2018, PENTAX Medical, a medical company engaged in diagnostic and therapeutic endoscopy, announced the U.S. launch of the DEFINA EPK-3000 Video Processor, along with the J10 Series Video Naso-Pharyngo-Laryngoscopes. The DEFINA EPK-3000 video processor combines superior functionality with vivid HD image processing and i-SCAN enhancement technology to give clean, clear HD images of nasal, pharyngeal, and laryngeal anatomy in a light and smaller system.
U.S. Endoscopy Video Processor Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 pandemic has affected various industries in the U.S. The players operating in the U.S. endoscopy video processor market are facing major challenges on various fronts due to the COVID-19 pandemic. According to the Coronavirus Disease (COVID-19) Weekly Epidemiological Update by the World Health Organization, the number of COVID-19 cases reported in the U.S. as of November 25, 2021, are approximately 258,830,438 confirmed cases with 5,174,646 deaths.
The coronavirus pandemic has negatively impacted the development, production, and supply of medical devices manufactured by various companies across the U.S. Moreover, the supply and production of these devices is also affected due to lockdown imposed in the U.S. during the COVID-19 pandemic. This lockdown has resulted in closure of industrial establishments, except manufacturing of essential commodities, and disruption in supply chain of the pharmaceutical products.